Axillary surgery in node-positive breast cancer()

Long-term follow-up data from multicenter phase III non-inferiority trials confirmed the safety of omission of axillary dissection in selected patients with clinically node-negative, sentinel node-positive breast cancer. Several ongoing trials investigate extended eligibility of the Z0011 protocol i...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggi, Nadia, Nussbaumer, Rahel, Holzer, Liezl, Weber, Walter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097794/
https://www.ncbi.nlm.nih.gov/pubmed/34511332
http://dx.doi.org/10.1016/j.breast.2021.08.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097794/
https://www.ncbi.nlm.nih.gov/pubmed/34511332
http://dx.doi.org/10.1016/j.breast.2021.08.018

Ejemplares similares